Registered entities
Contrafect Corporation
Reg. No. 39-2072586United States
CONTRAFECT CORP
Reg. No. 1478069United States
Innovation
31 patent families (11 granted) — focus: Human necessities, Chemistry & metallurgy, Emerging technologies; filing pace slowing. Cited 3,438 times.
| Year | Filings |
|---|---|
| 2014 | 3 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 8 |
| 2018 | 6 |
| 2019 | 11 |
| 2020 | 20 |
| 2021 | 22 |
| 2022 | 17 |
| 2023 | 17 |
| 2024 | 8 |
| 2025 | 6 |
Investor mix
7 investors on record; lead investors include Maxim Group.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 14% |
| Private equity | 1 | 14% |
| Bank & private debt | 1 | 14% |
| Other / undisclosed | 4 | 57% |
